Minerva Neurosciences Inc
(NAS:NERV)
$
3.14
0.06 (1.95%)
Market Cap: 21.96 Mil
Enterprise Value: -12.86 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 37/100 Minerva Neurosciences Inc (NERV) Transcripts
- Q1 2023 Minerva Neurosciences Inc Earnings Call TranscriptMay 15, 2023$6.44 (-11.42%)Earnings
- Q4 2022 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2023$1.87 (-7.65%)Earnings
- Q3 2022 Minerva Neurosciences Inc Earnings Call TranscriptNov 09, 2022$3.26 (+8.85%)Earnings
- Minerva Neurosciences Inc Roluperidone Update Call TranscriptApr 13, 2022
- Q3 2021 Minerva Neurosciences Inc Earnings Call TranscriptNov 08, 2021$11.28 (+4.44%)Earnings
- Q2 2021 Minerva Neurosciences Inc Earnings Call TranscriptAug 02, 2021$14.72Earnings
- Minerva Neurosciences Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- Q1 2021 Minerva Neurosciences Inc Earnings Call TranscriptMay 12, 2021$20.64 (+15.70%)Earnings
- Q4 2020 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2021$25.52 (+11.54%)Earnings
- Q3 2020 Minerva Neurosciences Inc Earnings Call TranscriptNov 02, 2020$24.8 (-3.43%)Earnings
- Minerva Neurosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 Minerva Neurosciences Inc Earnings Call TranscriptAug 03, 2020$29.52 (+5.88%)Earnings
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 19, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptJun 05, 2020
- Q1 2020 Minerva Neurosciences Inc Earnings Call TranscriptMay 04, 2020$78 (+3.83%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 31, 2020
- Q4 2019 Minerva Neurosciences Inc Earnings Call TranscriptMar 09, 2020$57.6 (-14.59%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 06, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptDec 18, 2019
- Q3 2019 Minerva Neurosciences Inc Earnings Call TranscriptNov 04, 2019$37.2 (+0.65%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptOct 01, 2019
- Q2 2019 Minerva Neurosciences Inc Earnings Call TranscriptAug 05, 2019$55.76 (+8.06%)Earnings
- Minerva Neurosciences Inc To Discuss The Results Of Its Successful Phase 2b Clinical Trial Of Seltorexant MIN-202 In Insomnia TranscriptJun 24, 2019
- Q1 2019 Minerva Neurosciences Inc Earnings Call TranscriptMay 06, 2019$57.52 (-5.15%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 21, 2019
- Q4 2018 Minerva Neurosciences Inc Earnings Call TranscriptMar 12, 2019$64.88 (-0.37%)Earnings
- 1